Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Micro-X Ltd. ( (AU:MX1) ) has shared an update.
Micro-X Ltd, a leader in cold cathode X-ray technology, announced its participation in a non-deal roadshow and the 19th Bioshares Conference. These engagements aim to enhance investor relations and showcase the company’s innovative products. The company’s strategic focus on expanding its US business and developing new applications for its technology, such as a next-generation airport security checkpoint and a full-body CT scanner, positions it for growth in both health and security sectors.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
More about Micro-X Ltd.
Micro-X Limited is an ASX listed hi-tech company specializing in the development and commercialization of innovative products for global health and security markets. The company leverages proprietary cold cathode, carbon nanotube emitter technology to create x-ray products that are smaller, lighter, and require less power, enhancing mobility and usability. Micro-X’s product portfolio includes mobile digital radiology products for healthcare, military, and veterinary applications, as well as security solutions for airport checkpoints and brain CT imagers for stroke diagnosis.
Average Trading Volume: 281,907
Technical Sentiment Signal: Sell
Current Market Cap: A$43.37M
Learn more about MX1 stock on TipRanks’ Stock Analysis page.